CD8 T cell responses to infectious pathogens

Annual Review of Immunology

Volumn 21, Issue , 2003, Pages 29-70

  Wong, Phillip ^a   Pamer, Eric G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bacteria; Cytotoxic T lymphocytes; Microbial immunity; Protozoans; Viruses

Indexed keywords

BACTERIAL VACCINE; CD40 LIGAND MONOCLONAL ANTIBODY; CD8 ANTIGEN;

ANIMAL MODEL; BACTERIAL INFECTION; CELL ACTIVITY; CELLULAR IMMUNITY; HEPATITIS B VIRUS; HERPES SIMPLEX VIRUS; HERPES VIRUS; IMMUNE RESPONSE; IMMUNIZATION; INFLUENZA VIRUS; LISTERIA MONOCYTOGENES; LISTERIOSIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICROBIAL IMMUNITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PLASMODIUM; PRIORITY JOURNAL; PROTOZOAL INFECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SALMONELLA TYPHIMURIUM; TOXOPLASMA GONDII; TRYPANOSOMA CRUZI; VIRUS INFECTION; ANIMAL; CD8+ T LYMPHOCYTE; DISEASE MODEL; HUMAN; IMMUNOLOGY; INFECTION;

ANIMALS; BACTERIAL INFECTIONS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HUMANS; INFECTION; MICE; PROTOZOAN INFECTIONS; VIRUS DISEASES;

EID: 0041468870     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.21.120601.141114     Document Type: Review

References (333)

1. Pamer E, Cresswell P. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323-58
2. Lefrancois L, Altman JD, Williams K, Olson S. 2000. Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells. J. Immunol. 164:725-32
3. Srivastava P. 2002. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 20:395-425
4. Carbone FR, Bevan MJ. 1990. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 171:377-87
5. Bevan MJ. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143:1283-88
6. + T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18:275-308
7. Borrow P, Tishon A, Oldstone MB. 1991. Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection. J. Exp. Med. 174:203-12
8. Matloubian M, Kolhekar SR, Somasundaram T, Ahmed R. 1993. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 67:7340-49
9. Marker O, Volkert M. 1973. Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice. J. Exp. Med. 137:1511-25
10. Moskophidis D, Assmann-Wischer U, Simon MM, Lehmann-Grube F. 1987. The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection. Eur. J. Immunol. 17:937-42
11. Murali-Krishna K, Altman JD, Suresh M, Sourdive D, Zajac A, Ahmed R. 1998. In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection. Adv. Exp. Med. Biol. 452:123-42
12. Ciurea A, Klenerman P, Hunziker L, Horvath E, Odermatt B, Ochsenbein AF, Hengarmer H, Zinkernagel RM. 1999. Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice. Proc. Natl. Acad. Sci. USA 96:11964-69
13. Zinkernagel RM, Planz O, Ehl S, Battegay M, Odermatt B, Klenerman P, Hengartner H. 1999. General and specific immunosuppression caused by antiviral T-cell responses. Immunol. Rev. 168:305-15
14. Fung-Leung WP, Kundig TM, Zinkernagel RM, Mak TW. 1991. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. J. Exp. Med. 174:1425-29
15. Gegin C, Lehmann-Grube F. 1992. Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope. J. Immunol. 149:3331-38
16. Kagi D, Seiler P, Pavlovic J, Ledermann B, Burki K, Zinkernagel RM, Hengarmer H. 1995. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and non-cytopathic viruses. Eur. J. Immunol. 25:3256-62
17. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758-61
18. Matloubian M, Suresh M, Glass A, Galvan M, Chow K, Whitmire JK, Walsh CM, Clark WR, Ahmed R. 1999. A role for perforin in downregulating T-cell responses during chronic viral infection. J. Virol. 73:2527-36
19. Gallimore A, Dumrese T, Hengarmer H, Zinkernagel RM, Rammensee HG. 1998. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J. Exp. Med. 187:1647-57
20. van der Most RG, Murali-Krishna K, Whitton JL, Oseroff C, Alexander J, Southwood S, Sidney J, Chesnut RW, Sette A, Ahmed R. 1998. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. Virology 240:158-67
21. van der Most RG, Sette A, Oseroff C, Alexander J, Murali-Krishna K, Lau LL, Southwood S, Sidney J, Chesnut RW, Matloubian M, Ahmed R. 1996. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 157:5543-54
22. Gallimore A, Hengarmer H, Zinkernagel R. 1998. Hierarchies of antigen-specific cytotoxic T-cell responses. Immunol. Rev. 164:29-36
23. + T cell response during acute LCMV infection. Adv. Exp. Med. Biol. 452:111-22
24. + T cells during an acute virus infection. Immunity 8:167-75
25. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, Miller JD, Slansky J, Ahmed R. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-87
26. Ciurea A, Klenerman P, Hunziker L, Horvath E, Senn BM, Ochsenbein AF, Hengarmer H, Zinkernagel RM. 2000. Viral persistence in vivo through selection of neutralizing antibody-escape variants. Proc. Natl. Acad. Sci. USA 97:2749-54
27. Planz O, Seiler P, Hengarmer H, Zinkernagel RM. 1996. Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies. Nature 382:726-29
28. Thomsen AR, Johansen J, Marker O, Christensen JP. 1996. ExhaUstion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. J. Immunol. 157:3074-80
29. + T-cell-deficient mice. J. Virol. 68:4700-4
30. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056-63
31. Lenz LL, Butz EA, Bevan MJ. 2000. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens. J. Exp. Med. 192:1135-42
32. Sigal LJ, Rock KL. 2000. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and- independent pathways of antigen presentation. J. Exp. Med. 192:1143-50
33. Suresh M, Whitmire JK, Harrington LE, Larsen CP, Pearson TC, Altman JD, Ahmed R. 2001. Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory. J. Immunol. 167:5565-73
34. Whitmire JK, Slifka MK, Grewal IS, Flavell RA, Ahmed R. 1996. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. J. Virol. 70:8375-81
35. + effector T cell responses. J. Immunol. 164:3689-97
36. + T-cell memory determined by clonal burst size. Nature 369:652-54
37. Blattman JN, Sourdive DJ, Murali-Krishna K, Ahmed R, Altman JD. 2000. Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection. J. Immunol. 165:6081-90
38. Sourdive DJ, Murali-Krishna K, Adtman JD, Zajac AJ, Whitmire JK, Pannetier C, Kourilsky P, Evavold B, Sette A, Ahmed R. 1998. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J. Exp. Med. 188:71-82
39. + T cells without selection of higher affinity TCR. Nat. Immunol. 2:711-17
40. Lau LL, Jamieson BD, Somasundaram T, Ahmed R. 1994. Cytotoxic T-cell memory without antigen. Nature 369:648-52
41. Freitas AA, Rocha B. 1999. Peripheral T cell survival. Curr. Opin. Immunol. 11:152-56
42. Murali-Krishna K, Lau LL, Sambhara S, Lemonnier F, Altman J, Ahmed R. 1999. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286:1377-81
43. Kassiotis G, Garcia S, Simpson E, Stockinger B. 2002. Impairment of immunological memory in the absence of MHC despite survival of memory T cells. Nat. Immunol. 3:244-50
44. + T cells during viral infection. J. Immunol. 166:795-99
45. + T cells. J. Immunol. 164:3950-54
46. Becker TC, Wherry EJ, Boone D, Murali-Krishna K, Antia R, Ma A, Ahmed R. 2002. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med. 195:1541-48
47. McNally JM, Zarozinski CC, Lin MY, Brehm MA, Chen HD, Welsh RM. 2001. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J. Virol. 75:5965-76
48. Selin LK, Lin MY, Kraemer KA, Pardoll DM, Schneck JP, Varga SM, Santolucito PA, Pinto AK, Welsh RM. 1999. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity 11:733-42
49. Selin LK, Vergilis K, Welsh RM, Nahill SR. 1996. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J. Exp. Med. 183:2489-99
50. Varga SM, Selin LK, Welsh RM. 2001. Independent regulation of lymphocytic choriomeningitis virus-specific T cell memory pools: relative stability of CD4 memory under conditions of CD8 memory T cell loss. J. Immunol. 166:1554-61
51. Selin LK, Nahill SR, Welsh RM. 1994. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 179:1933-43
52. + T cells in heterologous antiviral immunity and immunopathology in the lung. Nat. Immunol. 2:1067-76
53. Brehm MA, Pinto AK, Daniels KA, Schneck JP, Welsh RM, Selin LK. 2002. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat. Immunol. 3:627-34
54. Graham MB, Braciale TJ. 1997. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J. Exp. Med. 186:2063-68
55. + T cells clear influenza virus by perforin or Fas-dependent processes. J. Immunol. 159:5197-200
56. + T cells in primary and secondary influenza pneumonia. Immunity 8:683-91
57. + T cells. Proc. Natl. Acad. Sci. USA 96:8597-8602
58. + memory T cells specific for a subdominant epitope following Sendai virus infection. J. Immunol. 158:4301-9
59. + T cell response to influenza A viruses. J. Immunol. 165:2404-9
60. Chen W, Anton LC, Bennink JR, Yewdell JW. 2000. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12:83-93
61. + T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 193:1319-26
62. + T-cell response is much less apparent following secondary challenge. J. Virol. 74:3486-93
63. + T cell responses. J. Immunol. 166:4627-33
64. + T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen. J. Exp. Med. 191:1687-98
65. + T-cell memory is induced by Sendai virus infection of mice. J. Virol. 73:7278-86
66. Hendriks J, Gravestein LA, Tesselaar K, van Lier RA, Schumacher TN, Borst J. 2000. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1:433-40
67. Lumsden JM, Roberts JM, Harris NL, Peach RJ, Ronchese F. 2000. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection. J. Immunol. 164:79-85
68. Bertram EM, Lau P, Watts TH. 2002. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection. J. Immunol. 168:3777-85
69. DeBenedette MA, Wen T, Bachmann MF, Ohashi PS, Barber BH, Stocking KL, Peschon JJ, Watts TH. 1999. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J. Immunol. 163:4833-41
70. -/- mice. J. Virol. 74:9762-65
71. + T cell memory. J. Immunol. 164:3274-82
72. + T cells in the liver during the control and resolution phases of influenza pneumonia. Proc. Natl. Acad. Sci. USA 95:13812-17
73. + T cells. Proc. Natl. Acad. Sci. USA 98:6313-18
74. + T cells persist in the lungs following recovery from respiratory virus infections. J. Immunol. 166:1813-22
75. +) T cells persist in the upper respiratory tract following influenza virus infection. J. Immunol. 167:3293-99
76. Cerwenka A, Morgan TM, Dutton RW. 1999. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial. J. Immunol. 163:5535-43
77. + T cells to the lung during influenza pneumonia. J. Immunol. 167:6983-90
78. Usherwood EJ, Hogg TL, Woodland DL. 1999. Enumeration of antigen-presenting cells in mice infected with Sendai virus. J. Immunol. 162:3350-55
79. Falsey AR, Walsh EE. 2000. Respiratory syncytial virus infection in adults. Clin. Microbiol. Rev. 13:371-84
80. Harrington RD, Hooton TM, Hackman RC, Storch GA, Osborne B, Gleaves CA, Benson A, Meyers JD. 1992. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J. Infect. Dis. 165:987-93
81. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. 1999. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 282:1440-46
82. Hall CB, Walsh EE, Long CE, Schnabel KC. 1991. Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis. 163:693-98
83. + T cells. Clin. Exp. Immunol. 88:527-36
84. Cannon MJ, Openshaw PJ, Askonas BA. 1988. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168:1163-68
85. + lymphocytes, induced by infection with a vaccinia virus recombinant expressing the M2 protein of respiratory syncytial virus (RSV), correlates with resistance to RSV infection in mice. J. Virol. 67:1044-49
86. Graham BS. 1996. Immunological determinants of disease caused by respiratory syncytial virus. Trends Microbiol. 4:290-93
87. + T cells. Immunity 15:637-46
88. Schwarze J, Cieslewicz G, Joetham A, Ikemura T, Hamelmann E, Gelfand EW. 1999. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J. Immunol. 162:4207-11
89. Schwarze J, Makela M, Cieslewicz G, Dakhama A, Lahn M, Ikemura T, Joetham A, Gelfand EW. 1999. Transfer of the enhancing effect of respiratory syncytial virus infection on subsequent allergic airway sensitization by T lymphocytes. J. Immunol. 163:5729-34
90. + T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 27:3341-49
91. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J. Exp. Med. 186:421-32
92. Kulkarni AB, Collins PL, Bacik I, Yewdell JW, Bennink JR, Crowe JE Jr, Murphy BR. 1995. Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. J. Virol. 69:1261-64
93. Openshaw PJ, Anderson K, Wertz GW, Askonas BA. 1990. The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection. J. Virol. 64:1683-89
94. + T cells during experimental virus infection. J. Immunol. 167:4254-60
95. + T-cell memory in the respiratory tract. Nat. Med. 8:54-60
96. Aung S, Rutigliano JA, Graham BS. 2001. Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease. J. Virol. 75:9918-24
97. Aung S, Graham BS. 2000. IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity in vivo. J. Immunol. 164:3487-93
98. + respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo. J. Virol. 73:8944-49
99. Whitley RJ, Roizman B. 2001. Herpes simplex virus infections. Lancet 357:1513-18
100. Manickan E, Rouse BT. 1995. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse-models. J. Virol. 69:8178-79
101. Milligan GN, Bernstein DI. 1995. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology 212:481-89
102. Milligan GN, Bernstein DI. 1997. Interferon-γ enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 229:259-68
103. Fruh K, Ahn K, Djaballah H, Sempe P, van Endert PM, Tampe R, Peterson PA, Yang Y. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415-18
104. Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, Johnson D. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411-15
105. + T lymphocytes. Cell 77:525-35
106. Holterman AX, Rogers K, Edelmann K, Koelle DM, Corey L, Wilson CB. 1999. An important role for major histocompatibility complex class I-restricted T cells, and a limited role for γ interferon, in protection of mice against lethal herpes simplex virus infection. J. Virol. 73:2058-63
107. Kodukula P, Liu T, Rooijen NV, Jager MJ, Hendricks RL. 1999. Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. J. Immunol. 162:2895-2905
108. Liu T, Tang Q, Hendricks RL. 1996. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70:264-71
109. Simmons A, Tscharke DC. 1992. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. 175:1337-44
110. + T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 191:1459-66
111. + cell granules, restricts the spread of herpes simplex virus in the peripheral nervous systems of experimentally infected mice. J. Virol. 74:1029-32
112. Edelmann KH, Wilson CB. 2001. Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection. J. Virol. 75:612-21
113. + T cell responses and fail to contain virus infection of the central nervous system. J. Immunol. 166:1066-74
114. Coles RM, Mueller SN, Heath WR, Carbone FR, Brooks AG. 2002. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1. J. Immunol. 168:834-38
115. + T cell subset distribution in lymph nodes draining the site of herpes simplex virus infection. Eur. J. Immunol. 27:2310-16
116. McNally JM, Dempsey D, Wolcott RM, Chervenak R, Jennings SR. 1999. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection. J. Immunol. 163:675-81
117. + T cells identifies distinct responding subpopulations during the primary response to infection. J. Immunol. 165:2101-7
118. Wallace ME, Keating R, Heath WR, Carbone FR. 1999. The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J. Virol. 73:7619-26
119. Nugent CT, McNally JM, Chervenak R, Wolcott RM, Jennings SR. 1995. Differences in the recognition of CTL epitopes during primary and secondary responses to herpes simplex virus infection in vivo. Cell. Immunol. 165:55-64
120. Salvucci LA, Bonneau RH, Tevethia SS. 1995. Polymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes. J. Virol. 69:1122-31
121. Cose SC, Kelly JM, Carbone FR. 1995. Characterization of diverse primary herpes simplex virus type 1 gB-specific cytotoxic T-cell response showing a preferential V β bias. J. Virol. 69:5849-52
122. Wallace ME, Bryden M, Cose SC, Coles RM, Schumacher TN, Brooks A, Carbone FR. 2000. Junctional biases in the naive TCR repertoire control the CTL response to an immunodominant determinant of HSV-1. Immunity 12:547-56
123. Mueller SN, Jones CM, Smith CM, Heath WR, Carbone FR. 2002. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J. Exp. Med. 195:651-56
124. Guidotti LG, Matzke B, Schaller H, Chisari FV. 1995. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69:6158-69
125. Tsui LV, Guidotti LG, Ishikawa T, Chisari FV. 1995. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc. Natl. Acad. Sci. USA 92:12398-402
126. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36
127. McClary H, Koch R, Chisari FV, Guidotti LG. 2000. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J. Virol. 74:2255-64
128. Kakimi K, Lane TE, Wieland S, Asensio VC, Campbell IL, Chisari FV, Guidotti LG. 2001. Blocking chemokine responsive to γ-2/interferon (IFN)-γ inducible protein and monokine induced by IFN-γ activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J. Exp. Med. 194:1755-66
129. Pasquetto V, Guidotti LG, Kakimi K, Tsuji M, Chisari FV. 2000. Host-virus interactions during malaria infection in hepatitis B virus transgenic mice. J. Exp. Med. 192:529-36
130. Cavanaugh VJ, Guidotti LG, Chisari FV. 1997. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J. Virol. 71:3236-43
131. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-29
132. Ganem D. 1995. AIDS. Viruses, cytokines and Kaposi's sarcoma. Curr. Biol. 5:469-71
133. Moore PS, Chang Y. 2001. Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos. Trans. R. Soc. London Ser. B 356:499-516
134. Moss DJ, Burrows SR, Silins SL, Misko I, Khanna R. 2001. The immunology of Epstein-Barr virus infection. Philos. Trans. R. Soc. London Ser. B 356:475-88
135. Virgin HW, Speck SH. 1999. Unraveling immunity to γ-herpesviruses: a new model for understanding the role of immunity in chronic virus infection. Curr. Opin. Immunol. 11:371-79
136. Efstathiou S, Ho YM, Hall S, Styles CJ, Scott SD, Gompels UA. 1990. Murine herpesvirus 68 is genetically related to the γherpesviruses Epstein-Barr virus and herpesvirus saimiri. J. Gen. Virol. 71:1365-72
137. Virgin HW, Latreille P, Wamsley P, Hallsworth K, Weck KE, DalCanto AJ, Speck SH. 1997. Complete sequence and genomic analysis of murine γherpesvirus 68. J. Virol. 71:5894-904
138. Flano E, Husain SM, Sample JT, Woodland DL, Blackman MA. 2000. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J. Immunol. 165:1074-81
139. Stewart JP, Usherwood EJ, Ross A, Dyson H, Nash T. 1998. Lung epithelial cells are a major site of murine γherpesvirus persistence. J. Exp. Med. 187:1941-51
140. Sunil-Chandra NP, Efstathiou S, Nash AA. 1992. Murine γherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J. Gen. Virol. 73:3275-79
141. Weck KE, Kim SS, Virgin HW, Speck SH. 1999. Macrophages are the major reservoir of latent murine γherpesvirus 68 in peritoneal cells. J. Virol. 73:3273-83
142. Weck KE, Barkon ML, Yoo LI, Speck SH, Virgin HW. 1996. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine γherpesvirus 68. J. Virol. 70:6775-80
143. Ehtisham S, Sunil-Chandra NP, Nash AA. 1993. Pathogenesis of murine γherpesvirus infection in mice deficient in CD4 and CD8 T cells. J. Virol. 67:5247-52
144. + T cell control and morbidity. J. Gen. Virol. 82:1971-81
145. Usherwood EJ, Brooks JW, Sarawar SR, Cardin RD, Young WD, Allen DJ, Doherty PC, Nash AA. 1997. Immunological control of murine γherpesvirus infection is independent of perforin. J. Gen. Virol. 78:2025-30
146. + T cells. J. Exp. Med. 184:863-71
147. + T cell numbers are maintained during γ-herpesvirus reactivation in CD4-deficient mice. Proc. Natl. Acad. Sci. USA 95:15565-70
148. Sarawar SR, Cardin RD, Brooks JW, Mehrpooya M, Hamilton-Easton AM, Mo XY, Doherty PC. 1997. γ interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68. J. Virol. 71:3916-21
149. + T cell-mediated control of a γ-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. Proc. Natl. Acad. Sci. USA 96:5135-40
150. + T cells but confers minimal survival advantage on CD4-deficient mice. Proc. Natl. Acad. Sci. USA 97:2725-30
151. + T cells expanded by post-exposure vaccination of γ-herpesvirus-infected CD4-deficient mice. J. Immunol. 168:3477-83
152. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR. 1998. Help for cytotoxic-T-cen responses is mediated by CD40 signalling. Nature 393:478-80
153. + T-helper and a T-killer cell. Nature 393:474-78
154. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480-83
155. Sarawar SR, Lee BJ, Reiter SK, Schoenberger SP. 2001. Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus. Proc. Natl. Acad. Sci. USA 98:6325-29
156. Doherty PC, Christensen JP, Belz GT, Stevenson PG, Sangster MY. 2001. Dissecting the host response to a γ-herpesvirus. Philos. Trans. R. Soc. London Ser. B 356:581-93
157. + T cell response during acute and persistent murine γ-herpesvirus infection. Eur. J. Immunol. 29:1059-67
158. Liu L, Flano E, Usherwood EJ, Surman S, Blackman MA, Woodland DL. 1999. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection. J. Immunol. 163:868-74
159. Stevenson PG, Efstathiou S, Doherty PC, Lehner PJ. 2000. Inhibition of MHC class I-restricted antigen presentation by γ 2-herpesviruses. Proc. Natl. Acad. Sci. USA 97:8455-60
160. Parry CM, Simas JP, Smith VP, Stewart CA, Minson AC, Efstathiou S, Alcami A. 2000. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J. Exp. Med. 191:573-78
161. + peripheral blood T lymphocytes. Int. Immunol. 12:1193-1204
162. Tripp RA, Hamilton-Easton AM, Cardin RD, Nguyen P, Behm FG, Woodland DL, Doherty PC, Blackman MA. 1997. Pathogenesis of an infectious mononucleosis-like disease induced by a murine γ-herpesvirus: role for a viral superantigen? J. Exp. Med. 185:1641-50
163. Usherwood EJ, Ross AJ, Allen DJ, Nash AA. 1996. Murine γherpesvirus-induced splenomegaly: a critical role for CD4 T cells. J. Gen. Virol. 77:627-30
164. + T cells in vivo during latent murine γherpesvirus infection. J. Immunol. 163:1481-89
165. + T cell activation associated with latent murine γherpesvirus infection. J. Immunol. 163:3403-8
166. Stevenson PG, Doherty PC. 1999. Non-antigen-specific B-cell activation following murine γherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J. Virol. 73:1075-79
167. Kerksiek KM, Pamer EG. 1999. T cell responses to bacterial infection. Curr. Opin. Immunol. 11:400-5
168. + TCR-α β cells and IFN-γ in bacterial clearance independent of intracellular location. J. Immunol. 156:3321-26
169. + T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon γ and nitric oxide synthase 2. J. Exp. Med. 192:347-58
170. Portnoy DA, Chakraborty T, Goebel W, Cossart P. 1992. Molecular determinants of Listeria monocytogenes pathogenesis. Infect. Immun. 60:1263-67
171. Busch DH, Bouwer HG, Hinrichs D, Pamer EG. 1997. A nonamer peptide derived from Listeria monocytogenes metalloprotease is presented to cytolytic T lymphocytes. Infect. Immun. 65:5326-29
172. Geginat G, Schenk S, Skoberne M, Goebel W, Hof H. 2001. A novel approach of direct ex vivo epitope mapping identifies dominant and subdominant CD4 and CD8 T cell epitopes from Listeria monocytogenes. J. Immunol. 166:1877-84
173. Pamer EG. 1994. Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope. J. Immunol. 152:686-94
174. Pamer EG, Harty JT, Bevan MJ. 1991. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 353:852-55
175. Sijts AJ, Neisig A, Neefjes J, Pamer EG. 1996. Two Listeria monocytogenes CTL epitopes are processed from the same antigen with different efficiencies. J. Immunol. 156:683-92
176. Villanueva MS, Fischer P, Feen K, Pamer EG. 1994. Efficiency of MHC class I antigen processing: a quantitative analysis. Immunity 1:479-89
177. Villanueva MS, Sijts AJ, Pamer EG. 1995. Listeriolysin is processed efficiently into an MHC class I-associated epitope in Listeria monocytogenesinfected cells. J. Immunol. 155:5227-33
178. Varshavsky A. 1997. The N-end rule pathway of protein degradation. Genes Cells 2:13-28
179. Moors MA, Auerbuch V, Portnoy DA. 1999. Stability of the Listeria monocytogenes ActA protein in mammalian cells is regulated by the N-end rule pathway. Cell Microbiol. 1:249-57
180. Decatur AL, Portnoy DA. 2000. A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity. Science 290:992-95
181. Skoberne M, Holtappels R, Hof H, Geginat G. 2001. Dynamic antigen presentation patterns of Listeria monocytogenes-derived CD8 T cell epitopes in vivo. J. Immunol. 167:2209-18
182. Hess J, Gentschev I, Miko D, Welzel M, Ladel C, Goebel W, Kaufmann SH. 1996. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl. Acad. Sci. USA 93:1458-63
183. Grode L, Kaufmann SH, Hess J. 2001. Contribution of MHC class I-dependent immune mechanisms induced by attenuated recombinant Salmonella typhimurium secreting superoxide dismutase to protection against murine listeriosis. Vaccine 19:3269-72
184. Grode L, Kursar M, Fensterle J, Kaufmann SH, Hess J. 2002. Cell-mediated immunity induced by recombinant Mycobacterium bovis Bacille Calmette-Guerin strains against an intracellular bacterial pathogen: importance of antigen secretion or membrane-targeted antigen display as lipoprotein for vaccine efficacy. J. Immunol. 168:1869-76
185. Shen H, Miller JF, Fan X, Kolwyck D, Ahmed R, Harty JT. 1998. Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Cell 92:535-45
186. + T-cell priming against a nonsecreted Listeria monocytogenes antigen is independent of the antimicrobial activities of γ interferon. Infect. Immun. 68:2196-204
187. + T cells against exogenous proteins: establishment and characterization of a T cell line specific for the membrane protein ActA of Listeria monocytogenes. Eur. J. Immunol. 28:2630-39
188. Darji A, Bruder D, zur Lage S, Gerstel B, Chakraborty T, Wehland J, Weiss S. 1998. The role of the bacterial membrane protein ActA in immunity and protection against Listeria monocytogenes. J. Immunol. 161:2414-20
189. Vijh S, Pamer EG. 1997. Immunodominant and subdominant CTL responses to Listeria monocytogenes infection. J. Immunol. 158:3366-71
190. Vijh S, Pilip IM, Pamer EG. 1998. Effect of antigen-processing efficiency on in vivo T cell response magnitudes. J. Immunol. 160:3971-77
191. Vijh S, Pilip IM, Pamer EG. 1999. Non-competitive expansion of cytotoxic T lymphocytes specific for different antigens during bacterial infection. Infect. Immun. 67:1303-9
192. Yewdell JW, Bennink JR. 1999. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17:51-88
193. Busch DH, Pilip IM, Vijh S, Pamer EG. 1998. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 8:353-62
194. Mercado R, Vijh S, Allen SE, Kerksiek K, Pilip IM, Pamer EG. 2000. Early programming of T cell populations responding to bacterial infection. J. Immunol. 165:6833-39
195. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2:415-22
196. van Stipdonk MJ, Lemmens EE, Schoenberger SP. 2001. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2:423-29
197. Wong P, Pamer EG. 2001. Cutting edge: antigen-independent CD8 T cell proliferation. J. Immunol. 166:5864-68
198. + T cells after infection. Nat. Immunol. 3:619-26
199. + T cell response to Listeria monocytogenes in the absence of perforin and IFN-γ. J. Immunol. 164:6444-52
200. + T cell homeostasis by perforin and interferon-γ. Science 290:1354-58
201. Skoberne M, Geginat G. 2002. Efficient in vivo presentation of Listeria monocytogenes-derived CD4 and CD8 T cell epitopes in the absence of IFN-γ. J. Immunol. 168:1854-60
202. Busch DH, Kerksiek KM, Pamer EG. 2000. Differing roles of inflammation and antigen in T cell proliferation and memory generation. J. Immunol. 164:4063-70
203. + T cells following a microbe exposure. J. Immunol. 168:1198-1203
204. + T cells in IL-15 transgenic mice are involved in early protection against a primary infection with Listeria monocytogenes. Eur. J. Immunol. 31:757-66
205. + T cells. J. Immunol. 167:5603-9
206. + T lymphocytes during infection with Listeria monocytogenes. J. Immunol. 167:5620-27
207. + cytotoxic T cells in immune response against the intracellular bacteria Listeria monocytogenes. Immunology 95:226-33
208. Busch DH, Pilip I, Pamer EG. 1998. Evolution of a complex T cell receptor repertoire during primary and recall bacterial infection. J. Exp. Med. 188:61-70
209. Busch DH, Pamer EG. 1999. T cell affinity maturation by selective expansion during infection. J. Exp. Med. 189:701-10
210. Harty JT, Bevan MJ. 1995. Specific immunity to Listeria monocytogenes in the absence of IFN γ. Immunity 3:109-17
211. + T cells provide immunity to Listeria monocytogenes by a mechanism that is independent of CD95 and IFN-γ but requires TNF-α. J. Immunol. 160:898-905
212. + T cells derived from TNF-deficient and TNF/perforin double-deficient mice. J. Immunol. 165:5-9
213. + T cells are a biologically relevant source of macrophage inflammatory protein-1 α in vivo. J. Immunol. 162:5423-28
214. Miller MA, Skeen MJ, Ziegler HK. 1998. Long-lived protective immunity to Listeria is conferred by immunization with particulate or soluble listerial antigen preparations coadministered with IL-12. Cell Immunol 184:92-104
215. Rolph MS, Kaufmann SH. 2001. CD40 signaling converts a minimally immunogenic antigen into a potent vaccine against the intracellular pathogen Listeria monocytogenes. J. Immunol. 166:5115-21
216. Lauvau G, Vijh S, Kong P, Horng T, Kerksiek K, Serbina N, Tuma RA, Pamer EG. 2001. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science 294:1735-39
217. Masopust D, Vezys V, Marzo AL, Lefrancois L. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291:2413-17
218. Harty JT, Bevan MJ. 1996. CD8 T-cell recognition of macrophages and hepatocytes results in immunity to Listeria monocytogenes. Infect. Immun. 64:3632-40
219. Huleatt JW, Pilip I, Kerksiek K, Pamer EG. 2001. Intestinal and splenic T cell responses to enteric Listeria monocytogenes infection: distinct repertoires of responding CD8 T lymphocytes. J. Immunol. 166:4065-73
220. Pope C, Kim SK, Marzo A, Masopust D, Williams K, Jiang J, Shen H, Lefrancois L. 2001. Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection. J. Immunol. 166:3402-9
221. Hirose K, Suzuki H, Nishimura H, Mitani A, Washizu J, Matsuguchi T, Yoshikai Y. 1998. Interleukin- 15 may be responsible for early activation of intestinal intraepithelial lymphocytes after oral infection with Listeria monocytogenes in rats. Infect. Immun. 66:5677-83
222. Ma A, Boone DL, Lodolce JP. 2000. The pleiotropic functions of interleukin 15: not so interleukin 2-like after all. J. Exp. Med. 191:753-56
223. Bregenholt S, Berche P, Brombacher F, Di Santo JP. 2001. Conventional αβ T cells are sufficient for innate and adaptive immunity against enteric Listeria monocytogenes. J. Immunol. 166:1871-76
224. + T cells with cytolytic and protective activity. J. Immunol. 140:3173-79
225. Pamer EG, Wang CR, Flaherty L, Lindahl KF, Bevan MJ. 1992. H-2M3 presents a Listeria monocytogenes peptide to cytotoxic T lymphocytes. Cell 70:215-23
226. Kurlander RJ, Shawar SM, Brown ML, Rich RR. 1992. Specialized role for a murine class I-b MHC molecule in prokaryotic host defenses. Science 257:678-79
227. Gulden PH, Fischer P 3rd, Sherman NE, Wang W, Engelhard VH, Shabanowitz J, Hunt DF, Pamer EG. 1996. A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. Immunity 5:73-79
228. Lenz LL, Dere B, Bevan MJ. 1996. Identification of an H2-M3-restricted Listeria epitope: implications forantigen presentation by M3. Immunity 5:63-72
229. Princiotta MF, Lenz LL, Bevan MJ, Staerz UD. 1998. H2-M3 restricted presentation of a Listeria-derived leader peptide. J. Exp. Med. 187:1711-19
230. Kerksiek KM, Busch DH, Pamer EG. 2001. Variable immunodominance hierarches for H2-M3-restricted N-formyl peptides following bacterial infection. J. Immunol. 166:1132-40
231. Kerksiek KM, Busch DH, Pilip IM, Allen SE, Pamer EG. 1999. H2-M3-restricted T cells in bacterial infection: rapid primary but diminished memory responses. J. Exp. Med. 190:195-204
232. Bouwer HG, Barry RA, Hinrichs DJ. 2001. Lack of expansion of major histocompatibility complex class Ib-restricted effector cells following recovery from secondary infection with the intracellular pathogen Listeria monocytogenes. Infect. Immun. 69:2286-92
233. Seaman MS, Wang CR, Forman J. 2000. MHC class Ib-restricted CTL provide protection against primary and secondary Listeria monocytogenes infection. J. Immunol. 165:5192-201
234. Seaman MS, Perarnau B, Lindahl KF, Lemonnier FA, Forman J. 1999. Response to Listeria monocytogenes in mice lacking MHC class Ia molecules, J. Immunol. 162:5429-36
235. + T cells. J. Immunol. 165:4575-80
236. Chiu NM, Chun T, Fay M, Mandal M, Wang CR. 1999. The majority of H2-M3 is retained intracellularly in a peptide-receptive state and traffics to the cell surface in the presence of N-formylated peptides. J. Exp. Med. 190:423-34
237. Sponaas AM, Zuegel U, Weber S, Hurwitz R, Winter R, Lamer S, Jungblut PR, Kaufmann SH. 2001. Immunization with gp96 from Listeria monocytogenes-infected mice is due to N-formylated listerial peptides. J. Immunol. 167:6480-86
238. Kurlander RJ, Chao E, Fields J, Nataraj C. 1999. The adjacent flanking region plays a critical role in facilitating the presentation of the Listeria monocytogenes product lemA to H2 M3wt-restricted, peptide-specific murine CD8 cells. J. Immunol. 163:6741-47
239. + cytotoxic T cells. J. Exp. Med. 172:1083-90
240. Flynn JL, Weiss WR, Norris KA, Seifert HS, Kumar S, So M. 1990. Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivery system. Mol. Microbiol. 4:2111-18
241. Valentine PJ, Meyer K, Rivera MM, Lipps C, Pauza D, Maziarz RT, So M, Heffron F. 1996. Induction of SIV capsid-specific CTL and mucosal sIgA in mice immunized with a recombinant S. typhimurium aroA mutant. Vaccine 14:138-46
242. Russmann H, Shams H, Poblete F, Fu Y, Galan JE, Donis RO. 1998. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281:565-68
243. + memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope. Vaccine 20:577-85
244. Russmann H, Igwe EI, Saner J, Hardt WD, Bubert A, Geginat G. 2001. Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins. J. Immunol. 167:357-65
245. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding CV. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359-62
246. Svensson M, Stockinger B, Wick MJ. 1997. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells. J. Immunol. 158:4229-36
247. Kirby AC, Yrlid U, Svensson M, Wick MJ. 2001. Differential involvement of dendritic cell subsets during acute Salmonella infection. J. Immunol. 166:6802-11
248. Yrlid U, Svensson M, Hakansson A, Chambers BJ, Ljunggren HG, Wick MJ. 2001. In vivo activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium infection. Infect. Immun. 69:5726-35
249. Mittrucker HW, Kohler A, Kaufmann SH. 2002. Characterization of the murine T-lymphocyte response to Salmonella enterica serovar Typhimurium infection. Infect. Immun. 70:199-203
250. Mittrucker HW, Kohler A, Mak TW, Kaufmann SH. 1999. Critical role of CD28 in protective immunity against Salmonella typhimurium. J. Immunol. 163:6769-76
251. + T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. J. Immunol. 162:5398-406
252. Lo WF, Woods AS, DeCloux A, Cotter RJ, Metcalf ES, Soloski MJ. 2000. Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens. Nat. Med. 6:215-18
253. + T cells. Infect. Immun. 55:2037-41
254. + T cell lines. Eur. J. Immunol. 18:59-66
255. Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, Bennett LT, Bansal GP, Young JF, Lee MH, Haffull GF, et al. 1991. New use of BCG for recombinant vaccines. Nature 351:456-60
256. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89:12013-17
257. Behar SM, Dascher CC, Grusby MJ, Wang CR, Brenner MB. 1999. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189:1973-80
258. Sousa AO, Mazzaccaro RJ, Russell RG, Lee FK, Turner OC, Hong S, Van Kaer L, Bloom BR. 2000. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc. Natl. Acad. Sci. USA 97:4204-8
259. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. 2001. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193:271-80
260. +, T cells in lungs following aerosol infection with Mycobacterium tuberculosis. Infect. Immun. 67:3242-47
261. Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR, Flynn JL. 1999. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to tuberculosis. J. Immunol. 162:5407-16
262. van Pinxteren LA, Cassidy JP, Smedegaard BH, Agger EM, Andersen P. 2000. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur. J. Immunol. 30:3689-98
263. + T cells requires the production of γ interferon. Infect. Immun. 66:830-34
264. + T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect. Immun. 67:3980-88
265. + CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages. J. Immunol. 165:353-63
266. + T cells during Mycobacterium tuberculosis infection. J. Immunol. 167:6991-7000
267. Chun T, Serbina NV, Nolt D, Wang B, Chiu NM, Flynn JL, Wang CR. 2001. Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis. J. Exp. Med. 193:1213-20
268. + T cells with specifcity for a novel mycobacterial epitope. Int. Immunol. 13:451-58
269. + T cells and antibodies required for immunity to malaria sporozoites. Nature 330:664-66
270. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA 85:573-76
271. + cytotoxic T-cell clone recognizing sporozoite surface protein 2. Infect. Immun. 62:2979-83
272. + cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int. Immunol. 3:579-85
273. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F. 1989. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341:323-26
274. + cell-deficient β 2-m0/0 mice. J. Immunol. 151:3187-91
275. + T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria. J. Immunol. 144:1069-74
276. + T-cell responses against malaria liver stages. Nat. Med. 8:166-70
277. + T cells in immunity to malaria sporozoites. J. Immunol. 151:2690-98
278. Hoffman SL, Weiss W, Mellouk S, Sedegah M. 1990. Irradiated sporozoite vaccine induces cytotoxic T lymphocytes that recognize malaria antigens on the surface of infected hepatocytes. Immunol. Lett. 25:33-38
279. + T lymphocytes is required for protective immunity against Plasmodium berghei. J. Immunol. 156:3374-81
280. + T cell clones correlates with their levels of expression of adhesion molecules. J. Exp. Med. 175:895-905
281. Renggli J, Hahne M, Matile H, Betschart B, Tschopp J, Corradin G. 1997. Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity. Parasite Immunol. 19:145-48
282. Doolan DL, Hoffman SL. 2000. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165:1453-62
283. + T cells in the Plasmodium yoelii model. J. Immunol. 163:884-92
284. Klotz FW, Scheller LF, Seguin MC, Kumar N, Marietta MA, Green SJ, Azad AF. 1995. Co-localization of inducible-nitric oxide synthase and Plasmodium berghei in hepatocytes from rats immunized with irradiated sporozoites. J. Immunol. 154:3391-95
285. Nussler AK, Renia L, Pasquetto V, Miltgen F, Matile H, Mazier D. 1993. In vivo induction of the nitric oxide pathway in hepatocytes after injection with irradiated malaria sporozoites, malaria blood parasites or adjuvants. Eur. J. Immunol. 23:882-87
286. Schofield L, Ferreira A, Altszuler R, Nussenzweig V, Nussenzweig RS. 1987. Interferon-γ inhibits the intrahepatocytic development of malaria parasites in vitro. J. Immunol. 139:2020-25
287. + T cells. J. Exp. Med. 180:353-58
288. Sedegah M, Finkelman F, Hoffman SL. 1994. Interleukin 12 induction of interferon γ-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91:10700-2
289. Farkash AE, Maccabee PJ, Sher JH, Landesman SH, Hotson G. 1986. CNS toxoplasmosis in acquired immune deficiency syndrome: a clinical-pathological-radiological review of 12 cases. J. Neurol. Neurosurg. Psychiatry 49:744-48
290. Luft BJ, Brooks RG, Conley FK, McCabe RE, Remington JS. 1984. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA 252:913-17
291. + T cells in mice. J. Immunol. 140:3943-46
292. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol. 149:175-80
293. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146:286-92
294. Bliss SK, Gavrilescu LC, Alcaraz A, Denkers EY. 2001. Neutrophil depletion during Toxoplasma gondii infection leads to impaired immunity and lethal systemic pathology. Infect. Immun. 69:4898-905
295. Hunter CA, Subauste CS, Van Cleave VII, Remington JS. 1994. Production of γ interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor α. Infect. Immun. 62:2818-24
296. + T cell response by IFN-γ in IL-12-deficient mice during Toxoplasma gondii infection. J. Immunol. 162:5449-54
297. + T cell clone protects against acute Toxoplasma gondii infection in mice. J. Immunol. 152:1856-60
298. +) T cells prevent reactivation of Toxoplasma gondii infection in the immunocompromised host. Infect. Immun. 67:5869-76
299. + T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clin. Exp. Immunol. 84:207-12
300. + T lymphocytes are the major cell population involved in the early γ interferon response and resistance to acute primary Toxoplasma gondii infection in mice. Microbiol. Immunol. 38:789-96
301. + immune T cells against toxoplasmosis in mice. J. Immunol. 144:1954-56
302. + T cells. Infect. Immun. 70:434-43
303. + effector function against intracellular infection. J. Exp. Med. 184:131-39
304. + T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J. Immunol. 147:2310-16
305. + T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages. J. Immunol. 148:1493-98
306. + cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. J. Immunol. 147:3955-59
307. Denkers EY, Yap G, Scharton-Kersten T, Charest H, Butcher BA, Caspar P, Heiny S, Sher A. 1997. Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J. Immunol. 159:1903-8
308. Adams LB, Hibbs JB Jr, Taintor RR, Krahenbuhl JL. 1990. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J. Immunol. 144:2725-29
309. Deckert-Schluter M, Rang A, Weiner D, Huang S, Wiestler OD, Hof H, Schluter D. 1996. Interferon-γ receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation. Lab. Invest. 75:827-41
310. Khan IA, Matsuura T, Kasper LH. 1998. Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii. J. Immunol. 161:2994-3000
311. Scharton-Kersten TM, Yap G, Magram J, Sher A. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185:1261-73
312. + T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii. J. Immunol. 163:4503-9
313. + T cell-mediated immunity against Toxoplasma gondii infection in mice. J. Immunol. 157:2103-8
314. + T cell response. J. Exp. Med. 195:1463-70
315. Pentreath VW. 1995. Trypanosomiasis and the nervous system. Pathology and immunology. Trans. R. Soc. Trop. Med. Hyg. 89:9-15
316. Ley V, Robbins ES, Nussenzweig V, Andrews NW. 1990. The exit of Trypanosoma cruzi from the phagosome is inhibited by raising the pH of acidic compartments. J. Exp. Med. 171:401-13
317. Tardieux I, Webster P, Ravesloot J, Boron W, Lunn JA, Heuser JE, Andrews NW. 1992. Lysosome recruitment and fusion are early events required for trypanosome invasion of mammalian cells. Cell 71:1117-30
318. + T cell function to immune control of Trypanosoma cruzi. Parasite Immunol. 20:207-16
319. Rottenberg ME, Bakhiet M, Olsson T, Kristensson K, Mak T, Wigzell H, Orn A. 1993. Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect. Immun. 61:5129-33
320. Rottenberg ME, Riarte A, Sporrong L, Altcheh J, Petray P, Ruiz AM, Wigzell H, Orn A. 1995. Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8. Immunol. Lett. 45:53-60
321. Russo M, Starobinas N, Marcondes MC, Minoprio P, Honteyberie-Joskowicz M. 1996. The influence of T cell subsets on Trypanosoma cruzi multiplication in different organs. Immunol. Lett. 49:163-68
322. + T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J. Immunol. 144:717-24
323. Tarleton RL, Grusby MJ, Postan M, Glimcher LH. 1996. Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class H-restricted T cells in immune resistance and disease. Int. Immunol. 8:13-22
324. Tarleton RL, Koller BH, Latour A, Postan M. 1992. Susceptibility of β 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356:338-40
325. + TC1 responses. J. Immunol. 159:6120-30
326. + CTL. J. Immunol. 160:1817-23
327. +) T lymphocytes. Infect. Immun. 57:2246-48
328. +, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells. J. Immunol. 150:1446-57
329. Nickell SP, Sharma D. 2000. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance. Exp. Parasitol. 94:207-16
330. Reed SG. 1988. In vivo administration of recombinant IFN-γ induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. J. Immunol. 140:4342-47
331. Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, Reed SG. 1992. Interleukin 10 and interferon γ regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 175:169-74
332. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A. 1992. The microbicidal activity of interferon-γ-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-β. Eur. J. Immunol. 22:2501-6
333. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-12